Corrigendum to “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China”

In the article titled “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China” [1], there was an error in the value of the deceased patients, in the legend of Table 5, where “(n = XXX)” should be corrected to “(n = 9).” The corrected table and its legend are shown below.

Table 5.

Information of the deceased patients with SJS/TEN in this study (n = 9).

Phenotype	Sex	Age, y	Underlying disease	SCORTEN	Culprit drugs	Treatment
SJS	M	51	Chronic renal failure, diabetes	4	Allopurinol	Systemic steroids
TEN	M	70	Nil	6	Antibiotics	Systemic steroids
TEN	F	58	Aneurysm, subarachnoid hemorrhage	NA	Antibiotics	Systemic steroids
TEN	F	67	Rheumatic heart disease, mitral insufficiency	NA	Antibiotics and compound with aminopyrine, phenacetin, caffeine, phenobarbital	Systemic steroids with IVIG use in the late stage
TEN	F	71	Coronary heart disease, hypertension, diabetes, diabetic nephropathy	4	Calcium dobesilate	Systemic steroids with IVIG use in the early stage
TEN	M	62	Hypertension, diabetes	NA	Antibiotics	Systemic steroids with IVIG use in the early stage
TEN	M	94	Coronary heart disease, cardiac insufficiency, hypertension, diabetes, interstitial lung disease	NA	Antibiotics	Systemic steroids with IVIG use in the early stage
TEN	M	62	Hypertension, diabetes, chronic renal failure, hyperuricemia	NA	Allopurinol	Systemic steroids
TEN	M	3	Nil	2	Antibiotics	Systemic steroids

IVIG use in the early stage ≤ 7 days of onset, IVIG use in the late stage ≥ 7 days of onset. NA: not available.